Issues in designing a randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome: Comment on Wang et al. Randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. Int Urol Nephrol. 2016;48:13–18

2016 ◽  
Vol 49 (3) ◽  
pp. 457-458
Author(s):  
Dino Papeš ◽  
Miram Pasini ◽  
Ana Jerončić
Sign in / Sign up

Export Citation Format

Share Document